RxDoctor Payments Data

Michelle Butterworth

Foot & Ankle Surgery · Kingstree, SCNPI 1235229444

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Geistlich Pharma, North America, Inc. at 54.5% of the total. Reporting peaked in 2022 at $18,485 and has fallen 96.6% since, to $622 in 2025.

$54,061in general payments, 2019–2025

Across 120 payments — averaging $450.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Geistlich Pharma, North America, Inc.$29K
  • Paragon 28, Inc.$11K
  • Zimmer Biomet$3K
  • In2bones USA, LLC$3K
  • Heron Therapeutics, Inc.$2K
  • Extremity Medical$1K
  • plus $5K from 21 others

What the payments were for

  • Consulting fees$25,99848%
  • Speaking & faculty fees$7,50014%
  • Travel & lodging$10,44119%
  • Food & beverage$7,01313%
  • Education$3,1106%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,061 in reported general payments places this provider in the 85th percentile of 87 foot & ankle surgery providers in South Carolina.

See all foot & ankle surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$187,145
Medicare patients
582
Services billed
3,744

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole101$2,508
Ibuprofen108$1,194
Clindamycin Hcl58$643
Naproxen52$594
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav42$523
SsdSilver Sulfadiazine26$349
Prednisone66$297
Cephalexin37$289
Ciprofloxacin Hcl17$228
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen31$221
Diclofenac Sodium15$183
Silver Sulfadiazine18$181
Levofloxacin21$162
Terbinafine Hcl14$117
Meloxicam39$105

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Kingstree

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →